Recordati SpA (MIL:REC)
€ 51.1 0.05 (0.1%) Market Cap: 10.55 Bil Enterprise Value: 11.87 Bil PE Ratio: 25.26 PB Ratio: 5.61 GF Score: 95/100

Q1 2019 Recordati Industria Chimica e Farmaceutica SpA Earnings & 2019-2021 Business Plan Call Transcript

May 09, 2019 / 09:30AM GMT
Release Date Price: €35.37 (-3.02%)
Andrea Recordati
Recordati Industria Chimica e Farmaceutica S.p.A. - CEO & Director

I'm going to start as it's 10:31. Welcome. Thank you for coming to participate to the presentation of the global strategy, development strategy of Recordati and the objectives for the 2019 and '21 plan. You obviously already have insight in advance, insights on these numbers because they were released in the press release forming the Board of Directors yesterday. But obviously, the plan today is to give you more color and information on what lies behind this plan, so strategy-wise and the financials and sales functions-wise.

So for those of you who don't know Recordati because I know there are a few of you that don't know the company, I will go to Slide 4, please, Marianne, to give a quick profile of Recordati and what Recordati is today. Recordati is an Italian-originated pharmaceutical company. The company, obviously we closed 2018 with EUR 1.3 billion worth of sales. And we have 4,142 employees across the world. The company has 2 main business units, one is the specialty and primary care business unit,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot